rs61752962

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_002764.4(PRPS1):​c.477C>T​(p.Ile159Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00918 in 1,209,773 control chromosomes in the GnomAD database, including 45 homozygotes. There are 3,793 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0062 ( 3 hom., 174 hem., cov: 23)
Exomes 𝑓: 0.0095 ( 42 hom. 3619 hem. )

Consequence

PRPS1
NM_002764.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 1.95

Publications

2 publications found
Variant links:
Genes affected
PRPS1 (HGNC:9462): (phosphoribosyl pyrophosphate synthetase 1) This gene encodes an enzyme that catalyzes the phosphoribosylation of ribose 5-phosphate to 5-phosphoribosyl-1-pyrophosphate, which is necessary for purine metabolism and nucleotide biosynthesis. Defects in this gene are a cause of phosphoribosylpyrophosphate synthetase superactivity, Charcot-Marie-Tooth disease X-linked recessive type 5 and Arts Syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
PRPS1 Gene-Disease associations (from GenCC):
  • Arts syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Charcot-Marie-Tooth disease X-linked recessive 5
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • hearing loss, X-linked 1
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • phosphoribosylpyrophosphate synthetase superactivity
    Inheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • PRPS1 deficiency disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • mild phosphoribosylpyrophosphate synthetase superactivity
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe phosphoribosylpyrophosphate synthetase superactivity
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked nonsyndromic hearing loss
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant X-107642437-C-T is Benign according to our data. Variant chrX-107642437-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.95 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002764.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRPS1
NM_002764.4
MANE Select
c.477C>Tp.Ile159Ile
synonymous
Exon 4 of 7NP_002755.1P60891-1
PRPS1
NM_001204402.2
c.-82-2740C>T
intron
N/ANP_001191331.1B7ZB02

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRPS1
ENST00000372435.10
TSL:1 MANE Select
c.477C>Tp.Ile159Ile
synonymous
Exon 4 of 7ENSP00000361512.4P60891-1
PRPS1
ENST00000643795.2
c.477C>Tp.Ile159Ile
synonymous
Exon 4 of 7ENSP00000496286.1A0A2R8Y7H4
PRPS1
ENST00000372418.4
TSL:3
c.378C>Tp.Ile126Ile
synonymous
Exon 3 of 6ENSP00000361495.2B1ALA9

Frequencies

GnomAD3 genomes
AF:
0.00617
AC:
690
AN:
111845
Hom.:
3
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00191
Gnomad ASJ
AF:
0.00642
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0138
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.00837
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.0113
GnomAD2 exomes
AF:
0.00746
AC:
1368
AN:
183465
AF XY:
0.00872
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00248
Gnomad ASJ exome
AF:
0.00561
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00281
Gnomad NFE exome
AF:
0.0107
Gnomad OTH exome
AF:
0.00773
GnomAD4 exome
AF:
0.00949
AC:
10417
AN:
1097876
Hom.:
42
Cov.:
30
AF XY:
0.00996
AC XY:
3619
AN XY:
363242
show subpopulations
African (AFR)
AF:
0.000833
AC:
22
AN:
26398
American (AMR)
AF:
0.00244
AC:
86
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00568
AC:
110
AN:
19382
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30199
South Asian (SAS)
AF:
0.0156
AC:
843
AN:
54143
European-Finnish (FIN)
AF:
0.00358
AC:
145
AN:
40530
Middle Eastern (MID)
AF:
0.0155
AC:
64
AN:
4135
European-Non Finnish (NFE)
AF:
0.0104
AC:
8755
AN:
841795
Other (OTH)
AF:
0.00848
AC:
391
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
383
765
1148
1530
1913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00617
AC:
690
AN:
111897
Hom.:
3
Cov.:
23
AF XY:
0.00511
AC XY:
174
AN XY:
34081
show subpopulations
African (AFR)
AF:
0.00126
AC:
39
AN:
30868
American (AMR)
AF:
0.00191
AC:
20
AN:
10496
Ashkenazi Jewish (ASJ)
AF:
0.00642
AC:
17
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3566
South Asian (SAS)
AF:
0.0142
AC:
38
AN:
2670
European-Finnish (FIN)
AF:
0.00348
AC:
21
AN:
6029
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.0101
AC:
537
AN:
53190
Other (OTH)
AF:
0.0111
AC:
17
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00663
Hom.:
77
Bravo
AF:
0.00555
EpiCase
AF:
0.0100
EpiControl
AF:
0.0117

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
not provided (4)
-
-
2
Arts syndrome (2)
-
-
2
Hearing loss, X-linked 1 (2)
-
-
2
Phosphoribosylpyrophosphate synthetase superactivity (2)
-
-
1
Arts syndrome;C1839566:Charcot-Marie-Tooth disease X-linked recessive 5;C1844677:Hearing loss, X-linked 1;C1970827:Phosphoribosylpyrophosphate synthetase superactivity (1)
-
-
1
Charcot-Marie-Tooth disease X-linked recessive 5 (1)
-
-
1
Charcot-Marie-Tooth Neuropathy X (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
8.5
DANN
Benign
0.74
PhyloP100
1.9
PromoterAI
0.010
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61752962; hg19: chrX-106885667; COSMIC: COSV65054155; COSMIC: COSV65054155; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.